Nautilus Biotechnology, Inc.

NasdaqGS NAUT

Nautilus Biotechnology, Inc. Dividend Yield on January 14, 2025: 0.00%

Nautilus Biotechnology, Inc. Dividend Yield is 0.00% on January 14, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Nautilus Biotechnology, Inc. 52-week high Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
  • Nautilus Biotechnology, Inc. 52-week low Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
  • Nautilus Biotechnology, Inc. average Dividend Yield for the last 52 weeks is 0.00%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
NasdaqGS: NAUT

Nautilus Biotechnology, Inc.

CEO Mr. Sujal M. Patel
IPO Date Aug. 7, 2020
Location United States
Headquarters 2701 Eastlake Avenue East
Employees 161
Sector Health Care
Industries
Description

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Similar companies

MNOV

MediciNova, Inc.

USD 1.91

-4.02%

RZLT

Rezolute, Inc.

USD 4.72

-0.63%

RVMD

Revolution Medicines, Inc.

USD 39.83

-6.44%

BEAM

Beam Therapeutics Inc.

USD 23.30

-8.77%

CRBU

Caribou Biosciences, Inc.

USD 1.56

0.65%

IPSC

Century Therapeutics, Inc.

USD 0.94

-3.60%

KYMR

Kymera Therapeutics, Inc.

USD 40.12

7.79%

FHTX

Foghorn Therapeutics Inc.

USD 4.24

-2.97%

CCCC

C4 Therapeutics, Inc.

USD 3.74

6.86%

DTIL

Precision BioSciences, Inc.

USD 5.38

-6.27%

ANEB

Anebulo Pharmaceuticals, Inc.

USD 1.60

5.96%

PMVP

PMV Pharmaceuticals, Inc.

USD 1.35

-2.88%

CSBR

Champions Oncology, Inc.

USD 9.67

5.45%

StockViz Staff

January 15, 2025

Any question? Send us an email